Emostasi

Hemostasis and COVID-19

Hemostasis and COVID-19

Supporto ai laboratori nella diagnosi, nel trattamento e nella gestione delle anomalie della coagulazione in pazienti COVID-19

Reagenti INNOVANCE per la diagnosi e il monitoraggio delle anomalie della coagulazione

Reagenti INNOVANCE per la diagnosi e il monitoraggio delle anomalie della coagulazione

Supporto per la diagnosi precoce, il trattamento e la gestione delle infezioni COVID-19

Explore Integrated Platelet Aggregation Testing

Integrated Platelet Aggregation Testing

Manageable, reliable, and accessible with easy-to-use, standardized testing solutions. Learn more.

Third party publication: Assessment of Plasma Sample Quality on Siemens Atellica® COAG 360 System

Minimize repeat testing with reliable test results

Read more about how Atellica® COAG 360 System's quantification of HIL plasma indices can help reduce diagnostic errors.

World Thrombosis Day

World Thrombosis Day

Learn more about thrombosis risk factors and see how reliable diagnostic methods can help to stop deadly clots.

Hemostasis systems case studies

Case Studies

Hemostasis systems case studies

Automation workflow animation

Streamline your multidisciplinary testing

Watch the animation to learn how Siemens can provide a complete solution for automating workflow.

Hemostasis Online Campus

Hemostasis Online Campus

Rimanete aggiornati sulle nuove tendenze nelle analisi di coagulazione con Siemens Online Hemostasis Campus.

Solutions to meet the needs of every hemostasis lab

Migliorate il vostro laboratorio con un portfolio completo di prodotti Siemens per emostasi.

Continuous introductions of innovative technologies

Analizzatori, reagenti, software e supporto innovativi sono le fondamenta della nostra azienda

Thrombin Generation Cascade

Thrombin Generation Cascade

View the process of clot formation and learn about the fundamental role that thrombin plays in driving and regulating clotting activity.

Thrombophilia Cascade

Thrombophilia Cascade

View the processes involved in thrombophilia, a condition that leads to unwanted clot development, and how the activity of therapeutic agents can counteract its effects.